Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RACC
RACC logo

RACC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
10.380
Open
10.380
VWAP
10.38
Vol
1.00
Mkt Cap
94.44M
Low
10.380
Amount
10.38
EV/EBITDA(TTM)
--
Total Shares
9.10M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Research Alliance Corporation III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination.
Show More

Events Timeline

(ET)
2026-05-26
11:10:00
SpaceX Files for IPO Aiming to Raise $80 Billion
select
2026-05-20 (ET)
2026-05-20
11:50:00
Research Alliance Prices IPO at $10.00 per Share
select

News

renaissancecapital
8.5
05-22renaissancecapital
Three IPOs and Seven SPACs Priced This Week
  • Successful Pricing of Lincoln Financial: Lincoln Financial (LCLN) priced at $421 million, achieving a market cap of $2.2 billion, indicating strong demand in the private capital markets despite geopolitical and private credit concerns affecting peers.
  • Direct Listing of AMASS Brands: Beverage company AMASS Brands (AMSS) completed its direct listing on Nasdaq, yet its stock fell 52% from the $8.98 price of its last funding round, reflecting market caution towards its premium beverage platform.
  • Conexeu Sciences Surge: Medical device developer Conexeu Sciences (CNXU) completed a direct listing on Nasdaq, with its stock soaring 260% from the $4.00 price of its most recent private placement, showcasing investor enthusiasm for its unique regenerative medical technology.
  • SPACs Pricing Overview: Seven SPACs priced this week, with Oceanhawk Acquisition (OHACU) raising $160 million and Aperture AC (APURU) raising $90 million, demonstrating ongoing market interest in blank check companies despite an uncertain overall market environment.
seekingalpha
8.5
05-20seekingalpha
Research Alliance Corporation III Prices IPO at $10 per Share
  • IPO Pricing: Research Alliance Corporation III has successfully priced its initial public offering at $10 per share for 7.5 million Class A ordinary shares, raising a total of $75 million to fund future acquisitions.
  • Trading Launch: The company expects its shares to begin trading on the Nasdaq Capital Market on May 20 under the ticker symbol “RACC”, providing new investment opportunities for investors.
  • Acquisition Focus: Research Alliance Corporation III intends to target acquisitions in the healthcare and healthcare-related sectors, aiming to leverage industry growth potential to drive future company development.
  • Expected Closing: The offering is anticipated to close on May 21, subject to customary closing conditions, ensuring the funds are secured to support subsequent strategic initiatives.
renaissancecapital
8.5
05-20renaissancecapital
Research Alliance III Raises $75 Million for Healthcare SPAC
  • Funding Size: Research Alliance III successfully raised $75 million by offering 7.5 million shares at $10 each, indicating strong market interest and investment enthusiasm in the healthtech sector.
  • Increased Share Offering: Originally planning to offer 5 million shares, the company increased its offering earlier this month, reflecting robust demand for its investment opportunities, potentially providing greater financial support for future acquisitions.
  • Industry Focus: The SPAC targets healthcare-related industries, specifically drug development, commercialization, diagnostics, and healthcare technology services, aiming to drive innovation and growth through acquisitions, thereby strengthening RA Capital's influence in the sector.
  • Transaction Arrangement: The company will trade on Nasdaq under the symbol RACC, with Leerink Partners acting as the sole bookrunner for the deal, ensuring a smooth fundraising process.
Yahoo Finance
8.5
05-20Yahoo Finance
Research Alliance Corporation III Announces IPO Pricing
  • IPO Pricing Details: Research Alliance Corporation III has announced the pricing of its initial public offering at $10.00 per share for 7.5 million Class A ordinary shares, with the offering expected to close on May 21, 2026, reflecting market confidence in its future business combinations.
  • Listing Information: The shares will be listed on the Nasdaq Capital Market under the ticker symbol 'RACC', providing the company with broader access to capital and supporting its future acquisition strategies.
  • Management Team Background: Sponsored by an affiliate of RA Capital Management, the leadership of CEO Matthew Hammond, PhD, and COO Henry Stusnick is expected to provide a competitive edge in the healthcare sector, enhancing investor confidence in the company's strategic direction.
  • Investor Participation: The financing has attracted participation from several institutional investors, including ADAR1 Capital and Venrock Healthcare Capital Partners, indicating strong market interest and support, which further solidifies the company's capital foundation.
Wall Street analysts forecast RACC stock price to rise
0 Analyst Rating
Wall Street analysts forecast RACC stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Research Alliance Corporation III (RACC.O) is 0.00, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Research Alliance Corporation III's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
Current PE
0.00
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
Current PS
0.00
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding RACC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Research Alliance Corporation III (RACC) stock price today?

The current price of RACC is 10.38 USD — it has increased 0

What is Research Alliance Corporation III (RACC)'s business?

Research Alliance Corporation III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination.

What is the price predicton of RACC Stock?

Wall Street analysts forecast RACC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RACC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Research Alliance Corporation III (RACC)'s revenue for the last quarter?

Research Alliance Corporation III revenue for the last quarter amounts to NaN USD, decreased

What is Research Alliance Corporation III (RACC)'s earnings per share (EPS) for the last quarter?

Research Alliance Corporation III. EPS for the last quarter amounts to USD, decreased

How many employees does Research Alliance Corporation III (RACC). have?

Research Alliance Corporation III (RACC) has 0 emplpoyees as of June 13 2026.

What is Research Alliance Corporation III (RACC) market cap?

Today RACC has the market capitalization of 94.44M USD.